A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections

Inge C. Gyssens, Matthew Dryden, Peter Kujath, Dilip Nathwani, Nicolaas Schaper, Barbara Hampel, Peter Reimnitz, Jeff Alder, Pierre Arvis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2632-2642
JournalJournal of Antimicrobial Chemotherapy
Volume66
Issue number11
DOIs
Publication statusPublished - Nov 2011

Keywords

  • beta-lactams
  • randomized controlled trials
  • soft tissue infections
  • fluoroquinolones
  • sequential therapy

Cite this